The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response (2010)
- Autores:
- Autores USP: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- Assuntos: POLIMORFISMO; DOENÇAS CARDIOVASCULARES
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 46, suppl. 2, p. 77 res. FCF149, 2010
- Nome do evento: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo
-
ABNT
RODRIGUES, Alice Cristina et al. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 abr. 2024. , 2010 -
APA
Rodrigues, A. C., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Hirata, M. H., Dórea, E. L., et al. (2010). The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Rodrigues AC, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 77 res. FCF149.[citado 2024 abr. 18 ] -
Vancouver
Rodrigues AC, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 77 res. FCF149.[citado 2024 abr. 18 ] - Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
